Identification of Human Papilloma Virus Type 16 and 18 using Type Specific Primers in Normal Oral Mucosa, Epithelial Dysplasia and Oral Squamous Cell Carcinoma by Polymerase Chain Reaction by Raghu, Dhanapal
 IDENTIFICATION OF HUMAN PAPILLOMA VIRUS 
TYPE 16 AND 18 USING TYPE SPECIFIC PRIMERS IN 
NORMAL ORAL MUCOSA, EPITHELIAL DYSPLASIA 
AND ORAL SQUAMOUS CELL CARCINOMA BY 
POLYMERASE CHAIN REACTION  
 
 
Dissertation submitted to 
THE TAMILNADU DR. M. G. R.  MEDICAL UNIVERSITY 
In partial fulfillment for the Degree of 
MASTER OF DENTAL SURGERY  
 
 
 
 
 
BRANCH IV 
ORAL AND MAXILLOFACIAL PATHOLOGY 
March 2007 
 
 Acknowledgements 
All praise and honour to Lord Almighty for nothing can be done without HIS grace 
Words seem inadequate to express my deep sense of gratitude to my 
postgraduate teacher, mentor Dr. K. Ranganathan, MDS, MS (Ohio), Professor 
and Head, Department of Oral and Maxillofacial Pathology, Ragas Dental College 
& Hospital, for his valuable guidance, constant support, encouragement, for 
imparting knowledge and revealing the mysteries of carcinogenesis and guiding me 
with patience throughout my dissertation. 
My heartfelt gratitude to Dr. T. R. Saraswathi, MDS, M.Sc (Lon), Professor 
and Head of Department, Meenakshi Ammal Dental college for introducing me to the 
colorful world of pathology. 
I extend my sincere thanks to Dr. M. Uma Devi, Professor, Department of 
Oral and Maxillofacial Pathology, Ragas Dental College and Hospital, for her 
guidance, support and help throughout my postgraduate curriculum, and for her 
advice in completion of this work. 
 I earnestly thank Dr. Elizabeth Joshua, Associate Professor, Department of 
Oral and Maxillofacial Pathology, Ragas Dental College and Hospital for her 
constant encouragement throughout my study. 
Sincere thanks to the Principal, Dr. S. Ramachandran, Ragas Dental College 
and Hospital for his permission to use the facilities of the institution. 
 I thank Reader Dr. S. Nalin Kumar and lecturers, Dr. S. Balasundram & 
Dr. Sandhya, Department of Oral and Maxillofacial Pathology, Ragas Dental 
College and Hospital for their support throughout my post graduate curriculum. 
 I am deeply  indebted to Dr. Kondaiya for allowing me to utilize the lab 
facility in IISc Bangalore and for his guidance all throughout my study.  
I thank Dr. George Paul, Dr. Sarama Mathew, Dr. Sekhar, Dr. 
Sethuraman,  Dr. Elavarasan  in helping me with the case selection. 
I extend my gratitude to Dr. Vijayalakshmi, Dr. Pradeepa, Dr. Aravind, Dr 
Amathiya and all my lab mates in IISc Bangalore for their valuable advice and 
guidance 
I also thank Dr Rajkumar, Dr Nancy, Samson of cancer institute, Dr. H.N 
Madhavan, Dr. Lily Theresa, Adithi, Nalini of Sankara Nethralaya, Dr. 
Rajendran, Dr. Vikraman of IBMS, and Dr. Mary Thomas of M.G.R Medical 
university for their valuable advice and encouragement during the initial phases of 
my work. 
I acknowledge gratefully my entire batch mates Dr. Anthony George, Dr. 
Jayanthi P, Dr. Gauri Misra, Dr. Siva Kumar and Dr. Vidya L & also my friends 
Mahesh, Varun, Ankur, Raj, Sethu, Dany and Job. I thank all my seniors & 
juniors, for their constant help and support throughout my postgraduation.  
I extend my sincere thanks to Research Assistant Mrs. Kavitha, Bio-
statistician Mrs. Hemalatha, Lab Technician Mr. Rajan and Computer Assistant 
Mrs. Rupa Ragas Dental College and Hospital, for all the patience shown and the 
constant help they rendered in completion of this study. 
Last but not the least I specially thank my parents and brother for their love, 
understanding, support and prayers that have helped me during my work.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
 Cancer of the oral cavity is a major cause of morbidity and mortality 
worldwide. Among all cancers, oral cancer ranks sixth in the developed countries and 
third in India39. Exposure to risk factors such as tobacco smoking and chewing, 
alcohol and viral agents, increases the risk of occurrence of cancer. The role of certain 
viruses in oncogenesis has been established, and its study is an important source for 
the understanding of the molecular basis of multistep carcinogenesis.  
Viruses are derived from the Latin word "slime" or "poisonous juice". Viruses 
were not understood as unique entities until the 19th century 25. Viruses have the 
ability to alter the growth and morphology of the cell they infect. Human papilloma 
virus (HPV) has been shown to contribute to cervical and oral carcinogenesis. HPV 
infection is initially asymptomatic (latent) and transmission can occur between people 
before overt expression of the virus is seen 95. 
Papilloma viruses are small, non-enveloped viruses. They are double stranded 
DNA viruses with a circular DNA genome of about 8kb molecular weight. The 
viruses evade the immune system by evolution of viral variants. There are more than 
100 types of HPVs. In the oral cavity at least 36 HPV types are found 18.  The 
mucosal HPV types are commonly grouped into “high-risk” and “low-risk” categories 
on the basis of known epidemiologic associations with malignancy. High-risk types 
are frequently found in anogenital malignancies. Low-risk types are found in benign 
lesions such as warts 19.  
Maintenance of viral genome in the infected cells causes persistent infection. 
HPV infection of the dividing basal epithelial cells leads to a replication of the viral 
genome. These synthesize certain oncoproteins that have the potential to cause 
malignant transformation of the epithelial cells 59.  
   Studying the natural history and epidemiology of HPV is complex because of 
the presence of many subtypes. It is now known that HPV types 16 and 18 are 
carcinogenic to humans. Identification of HPV relies on the detection of viral DNA. 
HPV genome consists of three types of genes based on their function. They are early 
genes, late genes and long control region. Early and late genes produce early and late 
proteins. The long control region contains promoters and enhancers for the viral gene 
transcription. 
 Given the fact that all HPV types are closely related, assays can be designed to 
target conserved regions of the genome or regions whose sequences can best be used 
to discriminate different HPV types. Polymerase chain reaction (PCR) can be used to 
identify HPV DNA, as it is a sensitive technique for detection of even minimal 
quantities of viral DNA.  
Different samples, like liquid nitrogen frozen tissue, paraffin embedded tissue; 
exfoliated oral cells in saliva can act as a source of DNA for the identification of HPV 
DNA58, 46, 22. In case of samples processed from tissues originally fixed in 
formaldehyde and embedded in paraffin, the smaller the PCR amplification product 
the higher is the rate of HPV DNA detection3. 
The PCR technique can detect and amplify even small fragments of DNA or 
RNA. The automated machine helps in the analysis of a large number of samples. The 
PCR technique, can in ideal conditions, detect even one copy of viral DNA and 
therefore it is highly sensitive. The present study was undertaken to identify the 
presence of HPV in oral squamous cell carcinoma (OSCC), epithelial dysplasia and 
normal mucosa by PCR technique.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Aims & Objectives 
 AIMS AND OBJECTIVES 
1. To ascertain the presence of HPV 16 and 18 in sections from formalin 
fixed paraffin embedded tissue of normal oral mucosa by polymerase 
chain reaction (PCR). 
2. To ascertain the presence of HPV 16 and 18 in sections from formalin 
fixed paraffin embedded tissue of epithelial dysplasia by PCR. 
3. To ascertain the presence of HPV 16 and 18 in sections from formalin 
fixed paraffin embedded tissue of oral squamous cell carcinoma (OSCC) 
by PCR. 
 
 
HYPOTHESIS 
1. HPV 16 and 18 are present in epithelial dysplasia. 
2. HPV 16 and 18 are present in oral squamous cell carcinoma. 
3. HPV 16 and 18 are absent in normal mucosa 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Materials & Methods 
 
 Study Design 
A retrospective study was done to identify HPV DNA type 16 and 18 in 
oral squamous cell carcinoma (OSCC), epithelial dysplasia and normal oral 
mucosa.  
Study Groups 
Group I comprised of cases with oral squamous cell carcinoma  
Group II comprised of cases with epithelial dysplasia  
Group III comprised of cases with normal oral mucosa  
Study Setting 
The study was conducted in the Department of Oral and Maxillofacial 
Pathology at Ragas Dental College in collaboration with Department of 
Molecular Reproduction Development and Genetics, Indian Institute of Science, 
Bangalore.  
Tissue Specimens  
• Tissue specimens were retrieved from the archives of 35 
histopathologically confirmed OSCC cases, from January 2004 to 
December 2005. The amplification of the housekeeping gene was positive 
for 14 cases of the 35 cases. The final sample in Group I was thus limited 
to 14 cases. 
• Tissue specimens were retrieved from the archives of 15 
histopathologically confirmed epithelial dysplasia cases, from January 
2004 to December 2005. The amplification of the housekeeping gene was 
positive for 5 cases of the 15 cases. The final sample in Group II was thus 
limited to 5 cases. 
 • 10 normal oral mucosa were biopsied from cases, with no habit of 
smoking, alcohol consumption, chewing or any systemic disorders. In 
these 10 cases the amplification of the housekeeping gene was positive for 
4 cases. The final sample in Group III was thus limited to 4 cases.  
Patient profile, which included the age, gender, habit, site of the lesion and 
histopathology were documented for Group I, Group II (from the patient records) 
and for Group III, also the demographic characters were recorded. Informed 
consent was obtained for all patients from whom biopsy was obtained.  
Basic Armamentarium 
1. Microcentrifuge tubes  
2. Sterile tips 
3. Gloves 
4. Vials 0.2 / 0.5 µl 
5. Micropipettes 2 µl, 20µl, 200µl, 1000µl 
Armamentarium for DNA Extraction 
1. Xylene 
2. Ethanol 
3. Qiagen MiniAMP DNA extraction kit 
4. Thermostat (Eppendorf Thermostat Plus) 
5. Centrifuge (Sanyo Micro Centuar) 
Armamentarium for DNA Amplification 
1. Thermocycler (GENEAMP PCR system 9700) AB Biosystems  
 2. Master mix     (FINNZYMES – DyNAzyme II)  
i.  200 μl Deoxynucleotide Triphosphatase (dNTPs) 
ii.1.5 mM Magnesium Chloride (Mgcl) 
iii. 2.5 U Taq-polymerase 
3. HPV Primers 
i.  HPV 18 E1 primers  
Forward Primer 5’ CATTTTGTGAACAGGCAGAGC  
   Reverse Primer 5’ ACTTGTGCATCATTGTGGACC 
  ii. HPV 16 E7 primers 
   Forward Primer 5’ AGCTCAGAGGAGGAGGATGAA 
 Reverse Primer 5’ GGTTACAATATTGTAATGGGC 
4. House Keeping gene primers 
             i. Glutamate Dehydrogenase Primers 
   Forward Primer 5’ CTGGCTTGGCATACACAATG 
   Reverse Primer 5’ GCTGTTCTCAGGTCCAATCC  
Gel electrophoresis 
1. Agarose gel, Ethidium Bromide 
2. Parapin paper 
3. Bromophenol Blue Dye 
4. DNA Ladder 
5. Gel electrophoresis tank 
6. Voltmeter 
7. Gel Dock (Kodak Image Station 440) 
 Deparaffinisation of tissue sections 
The tissue sections were collected in the microcentrifuge tube; 40µm thick 
paraffin embedded section was used. Care was taken to prevent contamination 
during tissue sectioning. New blades were used for each block. After sectioning 
for one block the area was cleaned with xylene. 
1. 1200µl of xylene was added, pulse vortexed and centrifuged at full speed. 
The supernatant alone was removed. Caution was taken not to remove the 
pellet.  
2. 1200µl of 100% ethanol was added to remove xylene, pulse vortexed at 
slow speed and centrifuged at full speed. The supernatant alone was 
removed caution was taken not to remove the pellet.  
3. Ethanol from the pellet is removed completely by incubating the open 
microcentrifuge tube at 37 degree for 15 mins. 
DNA extraction 
1. 180μl Buffer ATL (composition not revealed by Qiagen) and 20µl of 
Proteinase K was added to the deparaffinised sample in the 
microcentrifuge tube and was incubated overnight at 56oC. 
2. 200µl Buffer AL was added into the microcentrifuge tube and mixed by 
pulse-vortexing for 15 sec and heated at 70 oC for 10 mins. 
3. The entire lysate was mixed with 200µl of 100% ethanol and was 
transferred to the silica based spin column with a collection tube and 
centrifuged (8000 rpm) for 1 min. 
4. The collection tube containing the flow-through filtrate was discarded. 
 5. After washing with wash buffers (AW1 and AW2), the spin column was 
eluted with 20µl of elution buffer and the filtrate of the samples collected 
in a new microcentrifuge tube was stored at  –20oC.  
6. The presence of DNA was checked on a 1% agarose gel (Figure: 9) and 
with a spectrometer at 260 nm. 
PCR AMPLIFICATION  
1. 25µl of the PCR master mix along with primer and autoclaved water was 
added for a final 50µl reaction. The cocktail of all these products were 
aliquoted into separate reaction tubes. 
2. Template was added separately into the different reaction tubes in a 
different room to avoid contamination. 
3. The final 50µl product was amplified in a Thermocycler.   
PCR Amplification of house keeping gene 
A fragment of the human Glutamate Dehydrogenase (Glu DH) gene was 
amplified with Glu DH primers.  
 A positive Glutamate Dehydrogenase amplification proved that the 
sample contains enough DNA and that no PCR inhibitors were present.  If the 
result of the house keeping gene amplification is negative the sample was not 
used.  
50µl of the reaction mixture should contain 1x concentrated master mix, 
1.5mmol MgCl2, 200 mmol dNTPs, 10 nanogram per lamda of each primer. 
 Calculation  
Master mix comes in 2x concentration (conc.) to make it 1x conc. 
  N1V1= N2V2 
For 50 µl Reaction: V2 = 25 µl of master mix for 1x reaction 
Cocktail preparation for one sample 
1x master mix      25 x 1 sample = 25 µl 
Forward Primer     1 x 1 sample = 1µl 
Reverse Primer      1 x 1 sample = 1µl 
DNA Template      3 x 1 sample = 3µl 
Autoclaved water is added to make up the remaining volume for 50 µl    
[50 – (25+1+1+3) =20µl] 
After an initial denaturation for 5 min at 94oC, each of the 35 cycles will 
denaturate for 1 min at 94oC, primer annealing for 2 min at 65oC, and chain 
elongation for 2 min at 72oC.  The last cycle will be followed by the incubation for 3 
min at 72oC.  
PCR Amplification HPV genes 
Samples with positive amplification of the control gene was subjected to HPV DNA 
detection with HPV 18 E1 gene type specific primers 
Forward Primer 5’ CATTTTGTGAACAGGCAGAGC  
   Reverse Primer 5’ ACTTGTGCATCATTGTGGACC  
This generated a 73 -bp long fragment of the E1 gene.  
Also detection of HPV 16 E7 gene type specific primers 
    Forward Primer 5’ AGCTCAGAGGAGGAGGATGAA 
    Reverse Primer 5’ GGTTACAATATTGTAATGGGC 
This generated a 75 -bp long fragment of the E7 gene.  
 Calculation  
Master  mix  comes  in  2x  conc.  to make it 1x conc. 
  N1V1= N2V2 
For 50 µl Reaction: V2 = 25 µl of master mix for 1x reaction 
Cocktail preparation for one sample 
1x master mix      25 x 1 sample = 25 µl 
Forward Primer     1 x 1 sample = 1µl 
Reverse Primer      1 x 1 sample = 1µl 
DNA Template      3 x 1 sample = 3µl 
Autoclaved water is added to make up the remaining volume for 50 µl  
[50 – (25+1+1+3) =20µl] 
After an initial denaturation for 3 min at 95oC, each of the 35 cycles will 
consist of 30 seconds of denaturation at 95oC, primer annealing for 30 seconds at 
55oC, and chain elongation for 30 seconds at 72oC. At the end an extra incubation for 
5 min at 72oC was carried out. 
Sterile water, DNA from SiHa, (a human cervical cancer cell line containing 
one or two copies of the HPV 16 genome per cell) and DNA from HeLa, (a human 
cervical cancer cell line containing ten to fifty copies of the HPV 18 genome per cell) 
will be included in every run as a positive control and negative control. 
The PCR products were electrophoresised on a 3% agarose gel, stained with 
ethidium bromide, visualised under ultraviolet light, and photographed. Samples that 
are positive by PCR revealed a clear band on the agarose gel (3%). 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Statistical Analysis 
 Data entry and statistical analysis was performed with the aid of Statistical 
Package for Social Science software version-10.0.05 (SPSS version 10.0.05). A 
descriptive analysis was presented for all variables.  
Pearson Chi-square test of association was used to find the association of 
HPV type 16 and 18 in different histological grades of oral squamous cell 
carcinoma (Group I), epithelial dysplasia (Group II), normal buccal mucosa 
(Group III), and to compare the presence of HPV between the above three 
groups. p <0.05 was considered statistically significant. 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Review of Literature 
 Papilloma virus  
 
History 
Shope and Hurst (1933)73 discovered the papilloma virus in cottontail 
rabbit as the first DNA virus to cause tumor in animals. It causes benign 
cutaneous papilloma in cottontail rabbit.  
Strauss MJ, Shaw EW, Bunting H et al (1949)76 showed the presence 
of viral particles by electron microscopy and also detected the presence of 
intranuclear inclusion bodies, in human warts. 
Meisels A and Fortin R (1976)53 were the first to study the role of 
papillomavirus infections in cervical smears and mild dysplastic lesions. The 
author stated that the presence of koilocytes in the smears indicate the presence of 
papillomavirus. 
Gissmann and zur Hausen (1977)29 identified and characterized 
different types of HPV by the use of molecular cloning. They also identified HPV 
types 6 and 11 in laryngeal warts.  
Durst M, Gissmann L, Ikenberg H (1983)20 identified the presence of 
HPV in cervical cancer tissue. The subtype HPV 16 was isolated from cervical 
cancer.  
Syrjanen K, Syrjanen S, Lamberg M (1983)81 showed the morphological 
and histopathological evidence of Human papilloma virus (HPV) in OSCC. They 
speculated the role of HPVs in the etiology of oral squamous cell carcinoma. 
  Von Knebel DM, Oltersdorf T, Schwarz E (1992)90 based on their 
observation stated that E6 and E7 genes are necessary factors for the malignant 
 phenotype of HPV positive cervical cancer cell lines and also for malignant 
transformation of nude mice cells. 
International Agency for Cancer Research Monograph (1995)35 stated 
that HPV16 and HPV18 were the causative agents for cancer of the cervix. 
Genital low risk HPVs are the etiological agents for condyloma, recurrent 
respiratory papillomas and papilloma at other mucosal surfaces. It was also 
established that transmission of the genital warts was through sexual contact. 
Transmission of all HPV types is more in the presence of an abraded epithelial 
surface.  
Miller CS, White DK (1996)56 reviewed the literature for the identification 
of the expression of HPV in oral mucosa, oral premalignant lesions and normal 
mucosa. He identified increasing frequency of HPV infection in normal oral 
mucosa than cancer cases. 
 
Pathogenesis 
Receptors of HPV 
Shafti-Keramat S, Handisurya A, Ernst K et al (2003)70 used two cell 
lines, one without heparan sulphate proteoglycan (HSPG) and other cell line with 
syndecan-1, syndecan-4, or glypican-1 and found that the binding of the virus 
like particle (VLP) was dependent on the presence of HSPG. Based on these 
results, the authors concluded that several HSPGs can serve as HPV receptor and 
that HSPGs is the primary receptor proteins for natural HPV infection of 
keratinocytes. 
 Genther Williams SM, Disbrow GL, Schlegel R et al (2005)28 used 
transgenic mice in which the E5 (Early) gene of the HPV16 was inserted into the 
Keratin 14 (K14) promoter. K14 is found in the basal layer of the stratified 
squamous epithelium, the site of papilloma viral infection. Epidermis of 
transgenic mice was used for immunohistochemical staining by 
bromodeoxyuridine (BrdUrd), which helps to determine DNA synthesis. 
Immunofluorescence staining for K14, keratin 10 (K10), and terminal 
deoxynucleotidyl transferase–mediated dUTP nick end labeling (TUNEL) was 
used for assessing epithelial hyperplasia. Western blot analysis was done to 
detect epidermal growth factor receptor (EGFR) after injecting epidermal growth 
factor to the mice .The mice with highest expression levels of E5 displayed the 
highest percentage of suprabasal DNA synthesis. Based on the phenotype and 
mutational assay the authors stated that requirement of EGFR is required for 
hyperplasia which is induced by E5 oncoprotein. 
Cell Entry  
Bousarghin L, Touze A, Sizaret PY et al (2003)6 the authors used drugs 
acting on the endocytosis, to study the entry of virions. They used virus like 
particle (VLP) and mediated pseudoinfection, to study the entry of these virions. 
VLP internalization was studied by electron microscopy. The endocytosis can be 
of two types clathrin and caveola mediated. The inhibitors of clathrin-coated 
vesicles (chlorpromazine) and caveola vesicles (nystatin) were used to study 
virion entry. HPV-16 and HPV-58 VLPs which used clathrin-coated vesicles, 
appeared as smooth grapes on the plasma membrane when examined by electron 
microscope. HPV-31 VLPs showed the presence of noncoated flask-shaped 
invaginations of the plasma membrane which had the characteristics of caveola 
 structures. Different types of HPV used different types of endocytosis to enter the 
cell. 
Yang R, Yutzy WH, Viscidi RP et al (2003)92 examined the transport of 
the virus like particles (VLP) with capsid proteins viz L1 and L2 inside the cell 
by means of confocal microscope. The microfilament actin is polymerised with 
the VLP, in the presence of the capsid proteins. The polymerization causes the 
particles to co-localize with the actin microfilaments and thus helps in the 
transport of the particles within the cell. 
Nuclear entry  
Day PM, Baker CC, Lowy DR, Schiller JT et al (2004)16 unraveled the 
HPV entry into nucleus. After the virus enters into the nucleus, finding a location 
in a preexisting transcription environment stimulates initial viral transcription. By 
using pseudogenome labeled with BrdUrd and tagged L2 protein, they showed 
that Papilloma viral L2 protein which mediates the delivery of the viral genome 
into the nucleus occurs at the Nuclear Domain 10 (ND 10) region. 
Viral Capsule 
Okun MM, Day PM, Greenstone HL et al (2001)63 examined the need 
for interaction between the capsid proteins L1 and L2 for encapsulation. In vitro 
study using bovine papilloma virus (BPV) L1 protein with BPV L2 protein led to 
encapsulation. BPV L1 with HPV L2 protein did not form a capsule, but chimeric 
(fusion proteins) of HPV L1 and BPV L2 protein led to encapsulation. L1-
binding to L2 is required prior to completion of capsid assembly was 
demonstrated by this experiment. 
 
 Viral Proteins  
Early 1 (E1) Protein 
Swindle CS, Engler JA et al (1998)80 showed that viral E1 protein is a 
DNA helicase responsible for initiation of DNA replication. E1 protein is 
recruited to the viral origin (starting site of replication), which is facilitated by 
binding to E2, for which specific recognition elements are located on the virus. 
The remaining replication functions for the virus, is provided by the host cell's 
replication machinery. The site of binding of the viral E1 protein to the host 
replicatory site was the histone protein 1(H1). H1 was identified as E1-binding 
protein by Western blotting in HPV type 11 (HPV-11). HPV origin facilitates 
initiation of DNA replication by exclusion of H1. 
Liu JS, Kuo SR, Makhov AM et al (1998)44 Human chaperon proteins 
(Hsp70 and Hsp40) independently and additively enhanced E1 binding to the site 
of replication as shown by electrophoretic mobility shift assays. This binding also 
leads to initiation of E1 mediated DNA replication. 
Maido R, Anu R, and Mart U et al (1999)48 proved that E1 protein is 
expressed from polycistronic mRNA containing E6, E7, and E1 open reading 
frames (ORFs). The translation of adjacent E7 and E1 ORFs is independent and 
is performed by separate populations of ribosomes. Ribosome scanning precedes 
the translation of the downstream E1 gene and the scanning happens at the 5' end 
of the polycistronic mRNA as shown by vector studies. They also established that 
the papillomavirus expression of replication protein E1 depends on a promoter in 
the flanking region or a specific mechanism that would ensure the expression of 
the E1 protein from the multicistronic messenger. 
 Ma T, Zou N, Lin BY, Chow LT et al (1999)47 did an in-vitro study 
using insect cell with plasmids of E1, E2, cyclin dependent kinase (Cdk) and 
cyclin E for protein interaction assay. HPV replication was studied by E1 
expression plasmids. Sequence analysis of cDNAs revealed several known Cdk-
interacting proteins, but E1 protein was the most abundant Cdk-interacting 
protein. E1 and E1/E2 were found to be associated with Cyclin E, independent of 
Cdk. It was also shown that ectopic expression of cyclin E could initiate 
replication independent of Rb inactivation in mammalian cells. Interaction of 
cyclin/Cdk complexes with E1 is critical for efficient replication, because 
cyclin/Cdk complex during HPV replication leads to phosphorylation of E1. 
Early 2 (E2) protein 
Masterson PJ, Stanley MA, Lewis AP et al (1998)52 by deletion mutant 
assay showed that E1 carboxy terminal was necessary for binding of E2 viral 
protein. E1 carboxy terminal also helped in binding to the viral origin of 
replication (ori). The use of antibodies blocked the DNA polymerase binding to 
E1, but not the E2 or ori binding. This was because the host DNA polymerase 
binds to a different site on E1 protein. 
Susanne IW, Delicia AF, Alla YK et al (2000)79 studied the effect of E2 
protein on HPV 18 positive cancer cell lines (HeLa). E2 viral protein was 
transfected along with the oncoproteins E6 and E7.Transfection with the full-
length E2 protein only resulted in a dramatic inhibition of cell colony formation 
on the medium (soft agar). E6 and E7 when coinfected with E2 resulted in the 
formation of cell colonies. Based on these results it is shown that HPV E2 
induces cellular senescence in HPV-positive cervical cancer cells and viral 
oncoproteins rescue HeLa cells from E2-induced senescence. 
 E5 protein 
Chen S L, Lin S T, Tsai T C et al (2006)12 studied the effect of HPV E5 
protein and its interaction with Erb-4 (tyrosine kinase receptor) by transfection of 
the cells. They examined the binding of HPV E5 protein to ErbB4, by using 10 
different ErbB4 deletion mutants. They were also able to show that HPV E5 
protein inhibited the c-Jun protein expression and phosphorylation, resulting in 
increased cell proliferation. The transfected cells were serum starved for 24 hrs, 
followed by treatment with Epidermal Growth Factor. Cell lysates were then 
analysed for c-jun antibody. 
Early 6 (E6) Oncoprotein 
 Kiyono T, Hiraiwa A, Fujita M et al (1997)41 in their study showed the 
effect of E6 oncoprotein on tumor suppressor protein, human homologue of the 
Drosophila discs large tumor suppressor (Dlg). Binding of viral oncoprotein E6 
to the Dlg protein was due to the presence of a PDZ domain (P-post-synaptic 
density protein, D-Dlg protein and Z-zonula occludens 1 protein) in the E6-
binding protein. The E6 protein of high-risk mucosotropic HPVs also has the 
similar conserved amino acid motif (part of aminoacid). This interaction causes 
degradation of Drosophila discs large tumor suppressor protein which in turn 
induces E6-dependent transformation of rodent cells. 
Patel D, Huang SM, Baglia LA, McCance DJ et al (1999)64 studied the 
effect of E6 oncoprotein on co-activators CBP and p300, which are required for 
cell differentiation and cell cycle progression. The binding of E6 oncoprotein 
binding to CBP and p300 caused an inhibition of the transcriptional activity of 
the co-activators. The authors demonstrated this inhibition of the transcriptional 
activity by an in-vitro experiment using promoter elements of various cellular 
 proteins that are transcriptional activated by co-activators of CBP and p300. E6 
could disrupt the binding of c-Fos to CBP .The activation of p53 and NF-κB by 
p300 is inhibited by E6 binding. 
Veldman T, Liu X, Yuan H, Schlegel R et al (2003)89 studied the 
functional role for Myc protein in E6-mediated activation of the human 
telomerase catalytic subunit gene’s (hTERT) promoter. In reporter assays in 
Human Foreskin Keratinocyte cells, Mad reduced E6-mediated activation of the 
hTERT promoter.  These authors showed that this decrease in promoter activity 
by Mad was the result of a specific repression on endogenous Myc activity, 
because overexpression of Myc restored E6 function to activate the hTERT 
promoter. Myc-binding site was necessary for E6-induced activation of the 
hTERT promoter. Based on this study it is concluded that E6 and Myc interact 
functionally to induce hTERT gene expression. The telomerase over expression 
in turn leads to cellular immortalisation. 
Stewart D, Ghosh A, Matlashewski G et al (2005)75 studied the 
coexpression of both p53 and high-risk HPV type 18 E6 (18E6) and also the 
shuttle for p53 from the nucleus to the cytoplasm. Inhibition of the nuclear export 
of p53 resulted in the partial degradation. The study showed that p53 in the 
cytoplasm was not targeted for degradation by 18E6 in vivo but could be 
degraded in vitro. 
Early 7 (E7) Oncoprotein 
 Jones DL, Alani RM, Munger K (1997)40 used an in-vitro study for 
evaluating the differentiation of human foreskin keratinocytes cells (HFK) and 
E7 infected HFK. From the cultured cells they studied epithelial differentiation 
 by means using differentiation markers involucrin and keratin 10. In HPV-16 
transfected keratinocyte that expresses E7 protein only after 72 hrs of induction, 
the differentiation markers were observed. They also determined the levels of 
p21Cip1 (Cdk inhibitor), which was considerably higher in HPV-16 E7-expressing 
keratinocytes compared with matched control cells at time intervals of 24 hrs and 
72 hrs after induction of differentiation. Also, high levels of p21Cip1 associated 
with cdk2 were detected in E7-expressing keratinocytes at 24 hrs and 72 hrs after 
keratinocyte differentiation. This shows that E7 interaction with p21 can cause an 
inhibition of p21 inhibitory activity on cyclins A and E and leads to DNA 
synthesis. 
Martin LG, Demers GW, Galloway et al (1998)51 studied the effect of 
E7 protein on different types of cyclins and Cyclin Dependent Kinase (Cdk) in 
human foreskin keratinocyte (HFK). HFK cells in the G1/S phase of cell cycle as 
determined by fluorescence assisted cell sorting (FACS). There was an increased 
expression of cyclin E as detected by IHC. This increased expression of cyclin E, 
based on the prediction that the disruption of the Rb-E2F pathway will lead to 
increased transcription of E2F-responsive genes. They found that there was no 
increase in the other E2F-responsive genes like cyclin A and cdc2. Based on this 
observation the authors concluded that the ability of the E7 to regulate cyclin E 
involves activities in addition to the release of E2F. 
Flores ER, Allen-Hoffmann BL, Lee D et al (2000)27 studied the 
immortalized human foreskin keratinocyte cell genome which existed in episomal 
form by transfecting it with the E7 deficient viral DNA. Episomal form is the 
state of the genome that is found in normal infections. The cells were cultured for 
E7-deficient HPV-16 genome and were found to have reduced amounts of the 
 capsid protein L1, which is required for virus production. These cells did not 
stain for the markers of keratinocyte differentiation, like keratin 10, involucrin, or 
filaggrin. E7 thus plays an essential role in the papillomavirus life cycle. 
Nguyen DX, Westbrook TF, McCance DJ et al (2002)61 studied the 
effect of E7 oncoprotein on cdc25 a cell cycle regulator. Using a reporter assay it 
is shown by these authors that E7 can transactivate the cdc25. The keratinocyte 
cells were serum starved which in turn decreased cdc25A gene transcription. In 
the presence of E7 it resulted in increased cdc25A gene expression. Based on 
these observations it is suggested that cdc25A is an important mediator of E7-
induced S-phase entry in carcinogenesis. 
Helt AM and Galloway D (2003)33 stated that the mechanism by which 
HPV E7 can inactivate Rb (Retinoblastoma) family of proteins is by a functional 
inactivation or by means of destruction of Rb protein. The functional inactivation 
is due to the inhibition of binding of Rb protein and E2F. There is inefficiency for 
E7 to completely inactivate Rb functionally. Therefore the accelerated destruction 
of the Rb of the family of proteins by means of the proteasome dependent 
pathway is the key factor causing altered Rb protein function.  
Late (capsid) proteins 
Florin L, Sapp C, Streeck RE (2002)26 showed that capsid proteins of 
HPV are preassembled in the cytoplasm and translocated to the nucleus. They 
also showed that the capsid proteins [late protein –1 (L1) and late protein - 2 
(L2)] translocated into the nucleus is independent of each other. These proteins 
then bind to nuclear domain 10 and then interact with each other.  
Yang R, Day P, Yutzy W (2003)91 in their in-vitro study showed that the 
late proteins (L1 and L2) were necessary for causing papillomavirus infection of 
 the host cell. L2 region on the virion, certain epitope was necessary for infection. 
They used virions with deleted regions of the epitope on the late proteins. 
Thereby they established that papillomavirus late proteins help to cause infection. 
Transmission of HPV 
International Agency for Cancer Research Monograph {IACR} 
(1995)35 reported that genital HPVs are transmitted primarily through sexual 
contact with infected cervical, vaginal, vulvar, penile or anal epithelium. Perinatal 
transmission, digital and oral transfers and autoinoculation of genital HPV types 
have also been documented. Transmission of all HPV types is probably more 
efficient in the presence of an abraded epithelial surface. HPV16 and HPV18 
were defined as causative agents for cancer of the cervix.  
Syrjanen S, Puronen M et al (2004)82 meta analysed the prevalence of 
HPV infection in children. Squamous cell papilloma has been estimated to 
account for about 7-8% of all oral tumors in children. PCR of oral scrapings 
detected 4% to 87% prevalence of HPV DNA in children. HPV DNA has been 
detected in 37% to 73% of nasopharyngeal aspirates. Laryngeal papillomas have 
a tendency to recur even after a radical surgical excision. In foreskins of 
newborns undergoing routine circumcision, 4% were found to contain HPV 
DNA. There is also evidence that transmission in utero or post-natal acquisition is 
possible. 
Bodaghi S, Wood LV, Roby G et al (2005)5 examined HPV DNA in 
frozen peripheral blood mononuclear cells (PBMCs) of HIV-infected pediatric 
cases and healthy blood donors. PCR was done with the PBNCs using L1 and 
two sets of HPV type-specific E6 and E2 primers. Eight pediatric HIV cases were 
 positive for HPV16 DNA (14%). Nested PCR confirmed the presence of 
episomal HPV16 DNA in the PBMCs, by detecting the head-tail junctions of 
episomal HPV16 genomes. Amplicons were sequenced and showed a correct 
head-tail junction. Presence of HPV DNA in prostatic tissue, sperm cells, and 
breast cancer raised the hypothesis that HPV DNA in PBMCs could spread and 
infect epithelial cells in other organs. 
 
Benign Cutaneous Lesion 
Yuan-Hong L, Xing-Hua G, Chin-Di H et al (2002)93 in a study of  two 
cases of Darier  disease found HPV subtypes 5, 36, 38 and 8 in one case and HPV 
5 and 36 in another case.  
 
Malignant Transformation Potential  - Cutaneous Disease 
Majewski S, Jablonska S et al (2002)49 reviewed the potential for 
malignant transformation in epidermodysplasia verruciformis (EV)) an inherited 
autosomal disease with heterogeneous clinical appearance. They stated that HPV 
types 5 & 8 commonly associated with EV are not recognized by the immune 
system and they induce mutation. EV HPV types are also associated with psoriasis. 
Cinzia M, Pawel GF, Fabrizio G et al (2003)13 studied EV associated with 
HPV  infections as a risk factor for development of skin cancer and suggested that 
HPV 8 can act as a co – factor in the development of cutaneous squamous cell 
carcinomas. 
 
 Benign Genital Lesions 
Brown DR, Schroeder JM, Bryan JT et al (1999)9 found that HPV 
types 6 and 11 are the major etiologic agents of condylomata acuminata lesions. 
In immunosuppressed cases the significance of additional “high risk” HPV types 
16, 55, and 59 in these lesions has not been established. Foci of high-grade 
dysplasia have been identified in condylomata acuminata lesions. 
Terai M, Takagi M, Matsukura T et al (1999)86 identified the presence 
of HPV in a case of oral viral wart based on histopathologic, 
immunohistochemistry and molecular studies (In-situ hybrisation and Southern 
blot assay).In this case they detected the presence of the subtype HPV 2. 
 Michael D (2005)54 stated that people with oral cancers containing the 
antibodies to HPV16 strain were three times more likely to report of having had 
oral sex than those in whom the tumour did not contain HPV16. Cases with oral 
cancer were also three times more likely to have antibodies against HPV than the 
healthy controls. 
 
Malignant Transformation 
Ferber MJ, Thorland EC, Brink AA (2003)24 used the RS–PCR 
technique to screen for HPV18 integration in a total of three HPV18-positive 
cervical carcinoma cell lines and 32 cases of HPV18-positive primary cervical 
carcinomas. Many of the HPV18 integration sites were found to occur in human 
repetitive sequences. Many of the integrations were also associated with deletions 
and/or complex rearrangements. By FISH method it was shown that the integration 
of HPV 18 occurred at Common Fragile sites (CFS), regions of genomic instability. 
 63% integration occurred in CFSs. 30% of all HPV18 integrations occurred at the 
chromosomal band 8q24 near the c-myc proto-oncogene. 
 
Pradip N, Kumaravel S, and Sudhir K (2003)66 by an in-vitro study 
analysed the relation between activated Notch1 (AcN1) and p53 function 
mediated through the PI3K pathway. Activation of a p53-dependent reporter 
showed that AcN1 reduces the induction of p53 sevenfold. In vitro 
transformation assays showed that activated forms of PKB/Akt along with AcN1 
and in the presence of E6, led to transformation of cells in soft agar. 
Al Moustafa AE, Foulkes WD, Benlimame N et al (2004)1 by an in-
vitro study examined the co-factor for HPV induced carcinogenesis in head and 
neck cancers. Overexpression of ErbB-2 or E6/E7 alone in normal oral epithelial 
cell lines does not affect E-cadherin/catenin complex pattern. There was a 
positive effect of the cooperation between oncoproteins E6 and E7 with ErbB-2 
receptor on the E-cadherin/catenin complex patterns, on the neoplastic 
transformation of human normal oral epithelial (NOE) cells. This was 
demonstrated by formation of colonies in soft agar and neoplastic transformation 
in nude mice. E6/E7/ErbB-2 cooperation induced nuclear translocation of β-
catenin, which in turn causes overexpression of cyclin D1 and c-myc this was 
determined by western blot assay. The upregulation of these proteins was 
suggested as a cause of neoplastic transformation. 
Oishee C, Karthikeyan V, Vinay T (2004)62 showed that the 
transforming potential of cell lines with a variant of E6 protein was dependent on 
the activation of mitogen-activated protein kinase (MAPK) signaling, which 
cooperates with deregulated Notch1 signaling. Transforming potential was shown 
 by increase in colonies in soft agar and formation of tumor in nude mice. This 
experiment also proved that Ras oncogene had no transforming effect on E6 
variant (alteration in amino acid-83). 
Schreiber K, Cannon RE, Karrison T (2004)68 studied the synergism of 
HPV16 E6/E7 and v-Ha-ras in vivo by using bitransgenic mice (E6/E7 and v-Ha-
ras) and it’s relation in transformation to some HPV-associated cancers. The 
prevalence rate of tumors in different sites in bitransgenic mice like mouth, eye 
and ear was 100, 71 and 79% respectively. However, in the single transgenic 
mice it was shown that there existed a latency of tumorigenesis. Thus the 
synergistic effect of E6/E7 and ras was established by this in-vivo study. 
Al Moustafa AE, Foulkes WD, Wong A (2004)2 in their experimental 
study used normal oral epithelium (NOE) and normal embryonic fibroblast 
transfected the cells with  E6/E7 alone and E6/E7/ErbB-2.They found that the 
size of soft agar colony among the cells with E6/E7 alone and E6/E7/ErbB-2 was 
different. In nude mice also the size of tumor was small when E6/E7 alone was 
used and large with E6/E7/ErbB-2. Failure to induce neoplastic transformation of 
cyclin D1 negative cells in the presence of E6/E7,ErbB-2   in vivo and in vitro 
was detected. This author concluded that cyclin D1 causes the neoplastic 
transformation in normal cells induced by E6/E7 or E6/E7/ErbB-2 cooperation. 
Fan X, Liu Y, Chen JJ (2005)23 investigated the mechanism of apoptosis 
during E6-mediated immortalization of primary human mammary epithelial cell 
(HMEC). Apoptosis observed in HMECs did not correlate with telomerase 
activity. Ectopic expression and down-regulation of the cyclin-dependent kinase 
inhibitor p21 Waf1/Cip1 by E6 was determined by western blot. This decrease in p21 
correlated with E6's ability to induce apoptosis. 
 Subramanyam D, Krishna S (2006)77 examined transformation of 
immortalised human epithelium cell lines (HaCaT cells) by c-myc signalling in 
the presence and absence of activated Notch-1 receptor along with the presence 
of oncoproteins E6. The authors, transfected HaCaT cells which normally 
expresses E7, with either Activated Notch-1 and E6 or c-Myc and E6 or co-
expression of c-myc and Notch-1, all the three groups resulted in increase in the 
number of colonies formed on soft agar. The results demonstrated that c-Myc 
could replace Activated Notch-1 in synergizing with the HPV oncogenes E6 and 
E7 and that the co-expression of c-Myc and Activated Notch-1 also did not affect 
transformation potential. Notch1 interacts with the DNA binding protein (CBF1) 
and causes the transcriptional regulation. This study also has shown that c-Myc 
can cooperate with E6/E7 in epithelial transformation and can substitute for 
CBF1-dependent signals generated by Notch-1.The outcome of this in-vitro 
study, identifies c-Myc as an important partner in HPV-mediated transformation 
of human epithelial cells. 
 
Cervical Cancer 
Burger RA, Monk BJ, Kurosaki T et al (1996)10 studied the presence of 
HPV in cervical cancer and its association with the clinical behaviour. There was 
no difference in survival in cases with HPV.  
Longworth MS, Laimins LA et al (2004)45 reviewed the pathogenesis of 
HPV infection in differentiating epithelia. The oncoprotein E6 of HPV binds to 
p53 along with ubiquitin ligase to form a tertiary complex, which causes a 
reduction of p53 half life from several hours to less than twenty minutes in 
keratinocytes. E6, to immortalize the epithelia should activate the expression of 
 catalytic telomerase. Immortalisation of human keratinocyte not only requires the 
above mechanism but also inactivation of Rb pathway by E7 oncoprotein. 
 
Normal Oral Mucosa 
Terai M, Hashimoto K, Yoda K et al (1999)85 detected that the 
prevalence of HPV in normal oral mucosa, in patients with skin warts and in 
patients without warts. A variation was seen in the frequency of human 
papillomavirus infections with a low copy numbers and also a difference was 
observed in the genotypes in both these oral mucosal specimens. These authors 
stated that the sensitivity of L1 primers is better than the type specific and general 
primers. Considering the fact that HPV was present in high numbers in the oral 
normal mucosa, the authors feel that oral mucosa is a normal reservoir for HPV. 
 Markette H, Jaana W, Hellevi R et al (2005)50 in their study help to 
determine the source of entry for latent HPV infection in the oral cavity. Based on 
the fact that HPV affects the basal cells and the exposed junctional epithelium 
resembles basal layer the decision to study the infectious gingival pocket as source 
of HPV detection was taken. The authors were able to detect HPV in 26% of the 
gingival biopsies of cases with periodontitis, with PCR using general primers and 
followed by the use oligoprobes for high risk HPV.   In-situ hybridisation results 
showed the presence of HPV in the coronal portion of the junctional epithelium. 
 
Benign Oral Lesions 
Miller CS, White DK (1996)56 reviewed literature from 1983 to 1995 for 
the identification of the expression of HPV in oral mucosa, oral premalignant 
lesions and OSCC. They identified increasing frequency of HPV infection in 
 normal mucosa (13.5%) leukoplakia (14.8%) and OSCC (26.2%). HPV was 
detected more readily with PCR and also in samples that were fresh and frozen 
rather than paraffin embedded.  
Miller CS, Johnstone BM (2001)57 conducted a meta analysis of 94 
articles published in Medline in English Literature to detect HPV in tissues or 
cells derived from normal oral mucosa, leukoplakia, carcinoma in-situ and oral 
cancer. The analysis was made by means of a random-effects model with and 
without adjustments for array sensitivity. The HPV was detected in 10% of 
normal oral mucosa, 22.2% of leukoplakia, 26.2% of carcinoma in situ, 29.5% of 
verrucous carcinoma and 46.5% of OSCC.    
Jimenez C, Correnti M, Salma K et al (2001)38 used PCR technique in 
biopsy specimens of normal oral mucosa and cases with squamous papilloma, 
oral condyloma, oral verruca vulgaris and focal epithelial hyperplasia. HPV DNA 
was detected in 41% of squamous papilloma, 50% of oral verruca vulgaris, 100% 
of oral condyloma, 100% of Heck’s disease and 10% of normal mucosa. HPV 6 
was the predominant type.  
Chen PC, Pan CC, Kuo C et al (2002)11 applied in situ-PCR to detect 
various HPV types. Their findings were as follows HPV 6 (11%), HPV 11 
(3.7%), HPV 16 (85.7%) and HPV 18 (71.4%). Using multivariate analysis it 
showed that HPV infection and betel quid chewing were independent risk factors 
in contrast to the hypothesis that when risk factors such as quid and HPV 
infection existed together they act synergistically. 
Sugiyama M, Bhawal UK, Dohmen T et al (2003)78 used paraffin 
embedded sections amplified by PCR to detect the presence of HPV in normal 
oral mucosa, leukoplakia, OSCC (oral squamous cell carcinoma) and found that 
 they were 36%,61%,35% respectively. In case of oral cancer cell lines HPV was 
detected in the early passage of cell culture, so HPV may be involved in the early 
phase of carcinogenesis. 
Jayasooriya P R, Abeyratne S, Ranasinghe A W et al (2004)37 case 
reports of two cases with multiple whitish nodules in the oral cavity diagnosed as 
Focal epithelial dysplasia (Heck’s disease) based on the histopathology. PCR 
detected HPV DNA in one case. 
 
Head And Neck Cancers 
 Roberto E V M, Luisia L V, Anoi C C et al (1998)67 determined the 
prevalence of HPV infection in head and neck cancers using frozen sections 
amplified by PCR. They found a prevalence of 11% HPV suggesting that 
chemical carcinogens play a more important role than HPV in cancer formation. 
Mork J, Lie AK, Glattre E et al (2001)58 in their study proposed HPV as 
a risk factor for head and neck cancer. They postulated that HPV DNA detection 
might lead to sampling errors in asymptomatic cases. They suggested that using 
capsid antibodies to HPV could be a reliable marker of previous and present HPV 
infection. The serum of 292 cases was examined and only 98 cases were positive 
from HPV capsid antibodies. In 228 of the biopsy specimens, HPV was detected 
in 160 tumor specimens. Smoking was excluded as a confounding factor using 
serum continine as marker. Other confounding risk factors could not be excluded. 
They suggested that a possible causative association between HPV and head and 
neck cancers could exist.  
 Herrero R, Castellsague X, Pawlita M et al (2003)34 in a multi-centric, 
case –control study of 1670 cases from 9 countries found a prevalence of 3.9% 
 HPV in oral squamous cell cancers and 18.9% oropharynx cancers. They used 
biopsy specimens stored in frozen condition and blood samples for detection of 
HPV DNA. HPV type 16 was found in 89.3% of cases, HPV16 and 18 in 5.4%, 
only HPV18 in one case. They conclude that HPV acts as the etiologic agent in a 
small subgroup of oral carcinoma.  
 Li W, Thompson CH, O'Brien CJ et al (2003)43 examined the 
expression and inactivation of genes operating within the p53 and pRb pathway, 
such as cyclin D1 and cyclin dependent kinase inhibitors p21, p16, p27 and also 
p53 and pRb proteins, in Tonsil cancer with HPV positivity / negativity and 
correlated it with the survival of the patient. Cell cycle proteins could not predict 
the recurrence and survival of the patient. Cases with HPV positive tumors were 
significantly less likely to have recurrence or die of the disease. Based on this 
they conclude HPV positive tonsil cancers are a distinct biologic group.  
 Gillison L (2004)30 suggested the fact that molecular changes for HPV 
positive head and neck carcinoma is different from other carcinomas and hence 
HPV positive cancers are considered, a distinct entity. In normal oral 
keratinocytes when transfected with HPV 16 alone, it caused immortalization of 
the cells but did not form tumors in nude mice. On further exposure to tobacco it 
caused tumor formation. 
Braakhuis BJ, Snijders PJ, Keune WJ et al (2004)8 found that HPV 
positive carcinomas had no p53 gene mutation when tested by direct genomic 
sequencing and lower level of allelic loss when studied with microsatellite 
marker for 3p, 9p, 17p chromosomes. HPV positive carcinomas had genetically 
distinct pattern of alteration and it could be an early event in carcinogenesis. 
  Zhang ZY, Sdeck P, Cao J et al (2004)94 were able to identify 55% HPV 
DNA subtypes 16/18 in normal mucosa and 74% in OSCC. Based on the previous 
studies the author feels that the use of Late gene (L) primer may give negative 
results, because the L1 and L2 regions may be lost during the HPV DNA 
integration into host DNA. The prevalence of HPV was more in young cases and 
predominantly in males. The authors suggested that the HPV alone is not a good 
predictor for progression to cancer because of its presence in normal mucosa.  
 Tachezy R, Klozar J and Salakova M et al (2005)83 examined the 
prevalence and subtypes of HPV in oral and oropharyngeal cancer. HPV DNA 
was detected in 51.5% of cases. HPV16 was the predominant type. HPV 33 was 
also detected in three cases. Since there was no association with smoking or 
alcohol drinking the author concluded that head and neck cancer positive for 
HPV are a different group epidemiologically and etiologically. 
 
Oral Cancer 
Syrjanen K, Syrjanen S, Lamberg M et al (1983)81 in their study they 
indicated the presence of HPV virus both morphologically and 
immunohistochemically. Their analysis showed morphologic alterations in 
superficial layer such as hyperkeratosis, dyskeratotic superficial cells, Deep 
layers showed acanthosis and koilocytosis, which is pathognomonic of HPV 
infection. Individual cells showed single cell dyskeratosis and multinucleation. 
They also identified immunohistochemically the presence of HPV in cancer 
tissue. 
Miller CS, Zeuss MS, White DK et al (1994)55 studied the prevalence of 
the subtypes HPV DNA in deparaffinised oral carcinoma specimens on slides 
 using in situ PCR. HPV 16 was detected in 69.2% of cases and HPV 18 in 28% 
of cases using in–situ PCR. HPV DNA was not detected in any specimens by in-
situ hybridization technique. Histomorphologic analysis by in–situ PCR of HPV 
altered epithelium (vacuolated cells) and in areas adjacent cancer tissue, did not 
show positive HPV DNA. 
 Haraf DJ, Nodzenski E, Brachman D et al (1996)32 examined the 
correlation between p53 and HPV infection in head & neck cancers, 24% of cases 
with p53 mutation was detected by direct genomic sequence. HPV infection was 
seen in 18% of 66 cases by PCR amplification. p53 mutation was seen in cases 
with history of smoking whereas HPV infection had an inverse relation with 
smoking. HPV infection was correlated with a more advanced stage of cancer and 
was associated with more favourable overall survival rate in stage IV cases. Thus, 
they concluded that p53 mutation and HPV infection occurred in different types 
of SCC of head & neck.  
Elamin F, Steingrimsdottir H, Wanakulasuriya S et al (1998)21 detected 
HPV in 14/28 cases of oral cancer and 4/12 cases premalignant lesions. Presence of 
HPV in premalignant lesions helped the authors to come to a hypothesis that HPV 
may be an early event in carcinogenesis. No association was seen between HPV 
and the tumor grade. 
Shima K, Kobayshi I and Saito I et al (2000)72 in their study found a 
significant relationship between HPV 16 of and p53 mutation. They suggest the 
HPV 16 has a mutagenic effect in oral OSCC. No significant relationship was 
observed between HPV infection and p53 mutation on survival of the patient.  
Glanna B, Aldo V and Armando B et al (2000)31 they examined cancers 
of head & neck they were able to detect HPV DNA by PCR in 1/3rd of cancers. 
 HPV was detected in 7(10) male cancer cases. High risk types HPV 16 and 18 
were mostly present, but low risk types were also present and dual subtype 
infections were also seen. In the oral cavity HPV was seen more in tongue and 
the second common site was the buccal mucosa. There was no relation to tumor 
differentiation in HPV positive samples. Using immunohistochemical techniques 
for the analysis of p53 and BCL-2 over expression, p53 staining was positive in 
tumors cell and negative for BCL-2. This in vivo study showed no links of HPV 
infection with p53 alteration and with BCL-2 expression, in contrast to in - vitro 
studies.  
 Lucia G, Giuseppina C and Anna L et al (2001)46 determined the 
presence of HPV DNA in different oral mucosal lesions. In squamous cell 
carcinoma the prevalence of HPV was higher (61.5%), 27.5% in potentially 
malignant lesions and 5.5% in controls. HPV type 18 was most prevalent 
genotype (85.7%) and HPV 16, 31 and 33 were rarely detected in this Italian 
study. In a different study HPV 18 was found predominantly in a genetically 
similar Greek population.  
Seth R S, Bevan Y, James K M et al (2001)69 studied the survival of 
HPV 16 positive OSCC cases (40) and HPV negative OSCC cases (214) with 
stage 3 or stage 4 cancer over a period of 54 months and controlling other known 
confounders of survival. The mean age in these HPV positive cancer cases was 
54.2, males were commonly affected and tumor of the tongue was commonly 
HPV positive. The authors concluded that HPV 16 DNA was independent of 
factors and was associated with a favourable prognosis. 
Kojima A, Marda H and Sugita Y et al (2002)42 studied the correlation 
between HPV 38 and the expression of the proliferative cell nuclear antigen 
 (PCNA) and p53 in OSCC. HPV 38 was positive in 38%. Positive staining with 
immunohistochemistry for PCNA and p53 was higher in HPV 38 positive OSCC.  
Tang X, Jia L, Ouyang J et al (2003)84 compared the prevalence of HPV 
16, 18 and 33 in Japanese and Chinese and the over expression of p53 in these 
cases. The prevalence of HPV 16 and 18 in both the populations was 46.7%. 
Over expression of p53 was more in HPV negative carcinomas. HPV 33 was not 
present in both the populations. A new fragment was detected on amplification of 
HPV 16 on genomic analysis and it was found to be the lost part of chromosome 
5. HPV and loss of chromosome 5 led to cancer development and its progression.  
Ibieta BR, Lizano M, Fras-Mendivil M et al (2005)36 in their study they 
found that HPV is a risk factor for oral squamous cell carcinoma. HPV infection, 
alcohol drinking and smoking are independent risk factors. They also suggested 
that women with cervical cancer should be studied for the status of HPV in the 
oral cavity.  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results 
 
 Thirty-five cases with a confirmed histopathology of oral squamous cell 
carcinoma, 15 cases of epithelial dysplasia and 10 of normal oral mucosa were 
included for the study. DNA extraction was done for all samples. For those that were 
negative the first time, DNA extraction method was modified and repeated again. 
DNA could be retrieved only from 23 cases as ascertained by positivity for the 
housekeeping gene, Glutamate Dehydrogenase (Glu DH) by Polymerase Chain 
Reaction (PCR). This was done to rule out the possibility of PCR inhibitors and 
absence of DNA integrity.  
Consequently the final sample was limited to 14 cases of OSCC (Group I), 5 
cases with epithelial dysplasia (Group II) and 4 controls with normal oral mucosal 
tissues (Group III). 
Mean age of cases in Group I was 58.4, 53 for Group II and 36.8 for Group 
III. In Group I there was 7(50%) males, in Group II all 5(100%) were males and in 
Group III 2(50%) of the cases were males. The male to female ratio was 1:1 in Group 
I and Group III. (Table 1 /Graph1). 
Out of all 14 cases of Group I, 8(57.1%) were from the buccal mucosa, 
1(7.1%) from alveolar mucosa, 2(14.3%) from the floor of the mouth, 1(7.1%) from 
gingiva, 1(7.1%) from labial mucosa and 1(7.1%) from the tongue. In Group II all of 
the cases were from buccal mucosa. In Group III 3(75%) were from buccal mucosa 
and 1(25%) from gingiva (Table 2 /Graph 2). 
All the cases in Group I and Group II had habits of chewing and smoking 
tobacco and consuming alcohol. In Group I, 6(42.9%) cases had habit of chewing 
arecanut and tobacco, 5(35.7%) were smokers, 3(21.4%) smoked tobacco and 
consumed alcohol. In Group II, 2 (40%) of the cases were smokers, 1 (20%) case had 
 the habit of chewing and smoking cigarettes, 1(20%) had the habit of both smoking 
and alcohol consumption and 1(20%) was a chewer and alcoholic (Table 3 /Graph 3). 
On histopathological examination in Group I 7(50%) was well differentiated, 
6(42.9%) were moderately differentiated and 1(7.1%) was poorly differentiated grade 
of carcinoma. In Group II 3(60%) had histology of mild dysplasia while 2(40%) 
exhibited moderate dysplasia (Table 4 /Graph 4).   
In the HPV 16 gel the positive control DNA from SiHa cell line and negative 
control DNA from HeLa cell line were added. Well-stained bands for SiHa were 
observed at 75 bp. The DNA ladder marker was added, on the last wells of each lane, 
with which the molecular weight was compared. 
In the HPV 18 gel the positive control DNA from HeLa cell line were added 
and negative control DNA from SiHa cell line were added. Well-stained bands for 
HeLa were observed at 73 bp. The DNA ladder marker was added, on the last wells of 
each lane, with which the molecular weight was compared. 
In the gel for house keeping gene Glu DH (Glutamate Dehydrogenase) PCR 
amplification the clear band was seen in 23 cases only (Figure: 10). 
The HPV 18 was detected in 3(21.4%) cases in Group I and was not detected 
in Group II and Group III (Figure: 11 /Table 5 /Graph 5) cases. There were three 
bands corresponding to the 73 bp size at level below the 100 bp ladder in 
correspondence with the level of the band for positive control HeLa, which indicated 
the presence of HPV 18.  
HPV 16 was not detected in Group I, Group II and Group III (Figure: 12). No 
band was detected at the 75 bp size (at a level below the last marking on 100 bp 
ladder) or in correspondence with the level of the band for positive controls SiHa in 
all three groups.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tables & Graphs 
 
 Table 1: Distribution of Gender in the Study Groups 
 
 
Graph 1: Distribution of Gender in the Study Groups 
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Male Female 
Groups 
n % n % 
p - value 
Group I  
Cancer  
(n = 14) 
7 50 7 50 
Group II   
Epithelial Dysplasia  
(n = 5)  
5 100 0 0 
Group III  
Normal  
(n = 4) 
2 50 2 50 
Total 14  9  
0.13 
 
  
Table 2: Distribution of Site in the Study Groups 
Sites 
Alveolar 
Mucosa 
Buccal 
Mucosa 
Floor of 
the 
mouth 
Gingiva 
Labial 
Mucosa 
Tongue Groups 
n % n % n % n % n % n % 
p - 
value 
Group I    
Cancer   
(n = 14) 
1 7.1 8 57 2 14 1 7.1 1 7.1 1 7.1 
Group II    
Epithelial 
dysplasia 
(n = 5) 
- - 5 100 - - - - - - - - 
Group III 
Normal 
(n = 4) 
- - 3 75 - - 1 25 - - - - 
0.82 
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Table 3: Distribution of Habits in the Study Groups 
Habit 
Chewer Smoker Chewer  
+ Smoker 
Smoker 
+ alcoholic 
Chewer + 
alcoholic 
P - value Groups 
n % n % n % n % n % 
Group I       
Cancer 
(n = 14) 
6 42.9 5 35.7 - 0 3 21.4 - 0 
Group II    
Epithelial 
dysplasia 
(n = 5) 
- - 2 40 1 20 1 20 1 20 
Group III 
Normal 
(n = 4) 
- - - - - - - - - - 
0.10 
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Table 4: Distribution of Histopathological Grading in the Study Groups 
Group I (n = 14) Group II (n = 5) 
Well 
differentiated 
Moderate 
differentiated 
Poor 
differentiated 
Mild  
dysplasia 
Moderate 
dysplasia 
n % n % n % n % n % 
7 50 6 42.9 1 7.1 3 60 2 40 
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Table 5: Distribution of HPV 18 in the Study Groups 
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Groups 
n  % n  % 
p-value 
Group I        
Cancer 
(n = 14) 
3 21.4 11  78.6 
Group II     
Epithelial dysplasia 
(n = 5) 
0 0 5  100 
Group III  
Normal 
(n = 4) 
0 0 4  100 
0.33 
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Discussion  
 
 Viruses have been identified as etiological agents in several types of human 
cancers. High-risk types of HPVs (16 and 18) have been established as the cause of 
invasive cervical cancer and anogenital carcinomas. An increasing evidence 
implicating viruses as etiological agents in the development of cancers of the upper 
aerodigestive tract is present in the literature19. The role of HPV as an etiological 
agent in oral cancer is supported by the fact that HPV DNA is present in oral cancer 
tissue and the observation that high risk HPV virus can also immortalize and 
transform normal oral epithelial cells. In this background the present study was 
conducted to detect the presence of HPV type 16 and 18 in OSCC, potentially 
premalignant lesions and normal mucosa. 
In this study the number of cases was fixed initially as 60 and the cases were 
selected after the histopathological diagnosis. Only 23 samples were used for the 
study as the housekeeping gene could be amplified only in these samples. The reason 
for this could be that, PCR inhibitors e.g. proteinase K, detergents (used for DNA 
extraction) may prevent the PCR amplification by inhibiting the activity of the 
thermostable enzymes14. The change in the DNA integrity is due to the cross linking 
with proteins induced by formaldehyde71. Thus this limitation should be considered 
when PCR technique is used in archival tissue. Consequently, to make DNA 
extraction possible it has been suggested that primers of amplicon size lesser than 200 
base pair should be used 3. Mork J et al (2001)58 in their study were able to extract 
DNA only from 160 of 228 cancer specimens which were formalin fixed and paraffin 
embedded. 
14 cases in Group I, 5 cases in Group II and 4 cases in Group III yielded 
satisfactory DNA content for PCR. 
 In Group I the mean age was 58.4, in Group II it was 53 and in Group III it 
was 36.8. In Group I and Group III, the male to female ratio was 1:1. In Group II all 
were males.   
 In Group I the predominant site was buccal mucosa (57.1%) and this finding 
was consistent with the report of Siriwardena B et al (2006)74. In Group III 75% 
percent of the cases were from the buccal mucosa and 25% from the gingiva. 
Markette H et al (2005)50 detected HPV in 26% of gingival biopsies and stated that 
gingiva could act as a possible reservoir of the virus. D’Costa J et al (1998)17 
suggested that the presence of HPV in normal oral mucosa could be due to a latent 
infection. 
In Group I (100%) and Group II (100%) all the cases had the habit of tobacco 
usage, some cases also consumed alcohol. Thavarajah R et al (2006)87 in their study 
of oral lesions in 500 psychoactive substance users, found that those who habitually 
used tobacco, alcohol and arecanut had a 20 fold higher risk of developing 
leukoplakia when compared to those who did not engage in these habits, in the Indian 
context. 
The Qiagen spin column based DNA extraction kit was used in our study for 
DNA extraction from sections of paraffin wax embedded tissue and the DNA so 
obtained was subjected to the polymerase chain reaction (PCR) for detection of house 
keeping gene and HPV DNA. Initially the house keeping gene primers, β – globin 
(220 bp size) and 18 S genes (300 bp) were tried. However, due to the lack of DNA 
integrity the efficiency of the PCR based amplifications of the house keeping genes 
was not effective for primers greater than 200 bp products. Similar findings have been 
reported by Baay M et al (1996)3 who suggested that when lesser than or equal to 200 
bp primers of amplicon product size were used for paraffin embedded samples 
 amplification was seen. Glutamate Dehydrogenase primers were then chosen as the 
housekeeping gene, as the amplicon product size was 88 bp.  
 Out of these 60 cases, the 23 samples for which housekeeping gene was 
positive by PCR were selected for the identification of HPV type 16 and 18.  
In the present study 3 cases (21%) of Group I, were positive for HPV 18, 
whereas none of the Group II and Group III cases were positive for either HPV 18 or 
HPV 16.  
Our results were comparable with that of Boy S et al (2006)7 who detected the 
presence of only HPV 18 by real time PCR in 7 cases of the 59 cases of OSCC. The 
site of the tumor, age and gender had no relation to the presence of HPV. Lucia G et 
al (2002)46 in their  study of  121 cases of OSCC and other mucosal lesions in an 
Italian population detected HPV 18 in 85%, of their cases and in contrast had a very 
low prevalence of HPV 16, 31 and 33. Balaram P et al (1995)4 reported HPV type 18 
in 47% and HPV 16 in 42% of 91 cases of OSCC in their study in the South Indian  
population unlike D’ Costa J et al (1998)17 who did not detect HPV type 18 in their 
study of OSCC, premalignant lesions and normal oral mucosa. In our study, HPV type 
18 was detected in 3 cases of OSCC. 
HPV 16 was not detected in any of the groups in our study. In contrast to our 
present study, D’Costa J et al (1998)17 in a North Indian population detected, only 
HPV 16 but not HPV 18 in oral cancers and potentially malignant lesions. The 
authors compared presence of HPV in the tissue sections of OSCC, potentially 
malignant lesions and normal appearing oral mucosa. They observed that, in 15 cases 
(15%) of OSCC, 27 cases (34%) of potentially malignant lesions and 15 cases (31%) 
of the corresponding normal mucosa the subtype HPV 16 only was present. No 
 correlation was observed in their study between the presence of HPV and gender, age 
and tumor stage and differentiation. 
We  could  probably  explain  the  absence  of  HPV  16  in  our  study  due  to 
the geographical  variation  as  documented  in  other  studies  among  different 
populations  84, 88, 46. 
 Among those cases, which were positive for HPV 18, two were well 
differentiated carcinomas and one was moderately differentiated carcinoma. This 
finding was similar to that of Elamin F et al (1998)21 who did not find an association 
between the presence of HPV and the grade of the tumor.  
In the HPV positive cases, 2 were female patients and one case was a male 
patient. Cruz I et al (1996)15 found a higher HPV prevalence in males than females in 
their study of  35 cases of OSCC. 
In our study group all the cases in which HPV was detected had the habit of 
chewing and smoking of tobacco. This correlation with tobacco and HPV detection 
has been reported by Elaine M et al (2004)22 in their study of 201 patients with head 
and neck cancers they found that tobacco had an additive effect and that alcohol 
consumption  had  a  synergistic effect with HPV positive cancers. In contrast, 
Herrero R et al (2003)34 reported lower HPV prevalence in tobacco chewers and 
smokers and Chen P et al (2002)11 did not find any association between HPV and 
tobacco associated habits. They concluded that both HPV and the habits acted as 
independent factors in the pathogenesis of cancer.  In our study, all the HPV positive 
cases were habitual users of tobacco indicating a possible correlation with tobacco as 
seen by Elaine M et al (2004)22. 
In our study, HPV 18 was detected in cases within the age range of  45 to 58 
with a mean age being 51 years. This finding is consistent with the observations by 
 Cruz I et al (1996)15 were they stated that HPV was predominantly detected only in 
the age below 60 years. The authors hypothesized that combined effects of the habits 
and HPV infection may lead to the early occurrence of OSCC in this age group. 
Another  possibility  is  that  an  infection  by  other  high risk  HPV  subtypes  such  
as  31, 33, 35 (i.e. other than HPV 16 and HPV 18) may account for those OSCC 
cases who were HPV negative and were below the age group of 60 years. Further 
studies would be required to explore this finding. 
The absence of HPV in premalignant lesions in our study could be due to a 
small sample size or the absence of the role of HPV in these lesions or the presence of 
other types of HPV, which were not studied. The results of this study indicate that 
HPV could be an etiological agent in some OSCC in patients below the age of 60 
years. Tobacco habits could also play a role along with HPV for the development of 
OSCC. This study also highlights that HPV induced cancers can be a separate 
subgroup of cancers, in those individuals who are lesser than 60 years of age. This 
could be due to the dual mutagenic effects of HPV and the combined effect of habits. 
In conclusion HPV 18 could be detected in 21% cases of oral cancer in this study, 
pointing to a possible role for HPV 18 in oral cancer. Further studies on a larger 
sample size could help to better understand the relation between HPV and oral cancer. 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Summary & Conclusion 
 
 • 60 cases were selected. Good quality DNA for house keeping gene amplification 
could be obtained only for 23 cases. 
• 23 cases were included in our study, divided into 3 groups.  
• In Group I, 14 cases were histopathologically confirmed cases of OSCC of which 
7 cases were well differentiated, 6 cases were moderately differentiated and 1 case 
was of poorly differentiated grade of OSCC. 
• In Group II, 5 cases were histopathologically confirmed cases of epithelial 
dysplasia  of which 3 cases had mild dysplasia and 2 cases had moderate 
dysplasia. 
• In Group III, normal oral mucosal tissues were obtained from 4 cases. 
• Male to female ratio was 1:1 in Group I and Group III. In Group II all were male 
patients. 
• Mean age of cases in Group I was 58.4, Group II was 53 and in Group III mean 
age was 36.8. 
• Tissues from the three groups were amplified for the identification of human 
papilloma virus type 16 and 18 using type specific primers by PCR method.  
• HPV 18 was detected in 3 cases of Group I 
• HPV18 was not detected in Group II and Group III 
• HPV 16 was not detected in Group I, Group II and Group III 
Our study indicates that HPV 18 has a probable role in the etiology of OSCC. 
However further studies in larger sample size will have to be done to establish this. 
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Annexure  
 
 HPV Types and Diseases 
HPV 
Type Location Association 
1 Cutaneous  Plantar warts  
2 Cutaneous  Common warts  
3 Cutaneous  Flat warts  
4 Cutaneous  Common and plantar Warts  
5 Genital tract, other mucosae 
Macular lesions in EV 
and cancers  
6 Genital tract, other mucosae 
Genital Warts, laryngeal 
papillomatosis  
7 Cutaneous  Butcher's warts  
8 Cutaneous  Macular lesions (EV) and cancers 
9 Cutaneous  Macular lesions (EV)  
10 Cutaneous Flat warts  
11 Genital tract, other mucosae Genital warts, laryngeal papillomas  
12 Cutaneous  Macular lesions (EV)  
13 Oral Oral focal epithelial hyperplasia  
14 Cutaneous  Macular lesions and cancers 
15 Cutaneous  Macular lesions 
16 Genital tract, other mucosae Intraepithelial neoplasia and cancers 
17 Cutaneous  Macular lesions (EV) and cancers  
18 Genital tract, other mucosae Intraepithelial neoplasia and cancers 
19 Cutaneous  Macular lesions (EV)  
20 Cutaneous  Macular lesions (EV) and cancers  
21 Cutaneous  Macular lesions (EV)  
22 Cutaneous  Macular lesions (EV)  
23 Cutaneous  Macular lesions (EV)  
24 Cutaneous  Macular lesions (EV)  
25 Cutaneous  Macular lesions (EV)  
26 Cutaneous  Common warts  
27 Cutaneous  Common warts  
28 Cutaneous  Flat warts  
29 Cutaneous  Common warts  
30 Genital tract, other mucosae Intraepithelial neoplasia and cancers 
31 Genital tract, other mucosae Intraepithelial neoplasia and cancers 
32 Oral Oral focal epithelial hyperplasia  
33 Genital tract Intraepithelial neoplasia and cancers 
34 Genital tract, other mucosae Intraepithelial neoplasia  
35 Genital tract, other mucosae Intraepithelial neoplasia and cancers 
 36 Cutaneous  Actinic keratosis, EV lesions  
37 Cutaneous  Not yet known, isolated from a keratoacanthoma  
38 Cutaneous  Not yet known, isolated from a melanoma  
39 Genital tract, other mucosae Intraepithelial neoplasia and cancer  
40 Genital tract, other mucosae Intraepithelial neoplasia and cancer  
41 Cutaneous  Flat warts  
42 Genital tract, other mucosae Intraepithelial neoplasia  
43 Genital tract, other mucosae Intraepithelial neoplasia  
44 Genital tract, other mucosae Intraepithelial neoplasia  
45 Genital tract, other mucosae Intraepithelial neoplasia  
46 Cutaneous  Macular lesions (EV)  
47 Cutaneous  Macular lesions (EV)  
48 Cutaneous  Cutaneous squamous cell carcinoma (Transplant patient) 
49 Cutaneous  Flat Warts in immunocompromised patient  
50 Cutaneous  Macular lesions (EV)  
51 Genital tract, other mucosae Intraepithelial neoplasia and cancers 
52 Genital tract, other mucosae Intraepithelial neoplasia and cancers 
53 Genital tract, other mucosae Intraepithelial neoplasia and cancers 
54 Genital tract, other mucosae Intraepithelial neoplasia and cancers 
55 Genital tract, other mucosae Intraepithelial neoplasia and cancers 
56 Genital tract, other mucosae Intraepithelial neoplasia and cancers 
57 Oral, genital  Oral papillomas and inverted maxillary sinus papillomas 
58 Genital tract, other mucosae Intraepithelial neoplasia and cancers 
59 Genital tract, other mucosae Anogenital intraepithelial neoplasia 
60 Cutaneous Epidermoid Cysts, plantar warts 
61 Genital tract, other mucosae Intraepithelial neoplasia 
62 Genital tract, other mucosae Intraepithelial neoplasia 
 63 Cutaneous Isolated from a plantar wart 
64 Genital tract, other mucosae Intraepithelial neoplasia 
65 Cutaneous Isolated from a pigmented wart 
66 Genital tract, other mucosae Intraepithelial neoplasia and cancers 
67 Genital tract, other mucosae 
Isolated from an intraepithelial 
neoplasia 
68 Genital tract, other mucosae 
Isolated from an intraepithelial 
neoplasia 
69 Genital tract, other mucosae Intraepithelial neoplasia and cancers 
70 Genital tract, other mucosae Isolated from a vulvar papilloma 
71 Genital tract, other mucosae 
Isolated from an intraepithelial 
neoplasia, 
72 Oral Isolated from an oral papilloma (HIV patient) 
73 Oral Isolated from an oral papilloma (HIV patient) 
74 Genital tract, other mucosae 
Isolated from an intraepithelial 
neoplasia, 
75 Cutaneous Isolated from a common wart in organ allograft recipient 
76 Cutaneous Isolated from a common wart in organ allograft recipient 
77 Cutaneous Isolated from a common wart in organ allograft recipient 
     
EV - Epidermodysplasia Verruciformis 
 
Oral HPV Types and Diseases 
Genotype Diseases 
HPV 2, 4  Verruca Vulgaris 
HPV 6, 11 Condyloma Acuminatum, Squamous Papilloma 
HPV 13, 32 Focal Epithelial Hyperplasia 
HPV 16 Proliferative Verrucous Leukoplakia 
HPV 6, 11, 16 Verrucous Carcinoma 
HPV 16, 18 Squamous Cell Carcinoma 
 
  
 
 
 
     
HPV Genome 
 
 
 
